Neurocrine Biosciences
NBIX
#1482
Rank
HK$93.15 B
Marketcap
HK$922.55
Share price
-1.75%
Change (1 day)
3.13%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of June 2024 : HK$25.76 B

According to Neurocrine Biosciences 's latest financial reports the company's total assets are HK$25.76 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$25.39 B37.21%
2022-12-31HK$18.50 B14.52%
2021-12-31HK$16.16 B20.15%
2020-12-31HK$13.45 B32.22%
2019-12-31HK$10.17 B30.8%
2018-12-31HK$7.77 B21.75%
2017-12-31HK$6.38 B125.63%
2016-12-31HK$2.83 B-23.06%
2015-12-31HK$3.67 B95.15%
2014-12-31HK$1.88 B57.2%
2013-12-31HK$1.19 B-21.04%
2012-12-31HK$1.51 B41.35%
2011-12-31HK$1.07 B-4.37%
2010-12-31HK$1.12 B104.62%
2009-12-31HK$0.54 B-40.04%
2008-12-31HK$0.91 B-57.58%
2007-12-31HK$2.15 B-28.76%
2006-12-31HK$3.03 B-19.09%
2005-12-31HK$3.74 B3.06%
2004-12-31HK$3.63 B-15.64%
2003-12-31HK$4.30 B107.25%
2002-12-31HK$2.07 B-23.03%
2001-12-31HK$2.70 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$22.30 B-13.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$137.63 B 434.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$88.91 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$560.26 B 2,074.73%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.106 T 4,194.61%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.685 T 6,441.39%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.17 B-72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.9 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA